Shoulder Innovations, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $389.5M
- Price
- $18.71
- % Change (Daily % change from the live per-ticker quote feed.)
- -2.25%
- Volume
- 81.8K
About
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
Quick stats
Shares outstanding20.8M
Computed float12.0M
Float / shares57.7%
Cash runway (months)28
Key info
SectorHealthcare
IndustryMedical - Specialties
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001699350
AI Summary
AI-generated1/23
standardbullishfda approval
Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch
Shoulder Innovations received FDA 510(k) clearance for the N-22 Humeral Head, a titanium implant for shoulder arthroplasty patients with metal hypersensitivity, and simultaneously initiated its full commercial launch.
The Humeral Head is the second product on the company's metal-sensitive technology line, complementing the N-22 Glenosphere cleared in January 2026, and addresses a population where roughly 10% to 15% of people test positive for metal hypersensitivity.
CEO Rob Ball said the clearance gives surgeons a metal-sensitive option across both anatomic and reverse shoulder arthroplasty configurations, reinforcing the company's surgeon and operating-center relationships as it expands its U.S. commercial footprint.